Poor outcome of patients with pulmonary arterial hypertension with insufficient response to phosphodiesterase-5 inhibitors alone or in combination with other specific therapy: a registry-based study

Phosphodiesterase-5 inhibitors are commonly used in pulmonary arterial hypertension but, as suggested by the RESPITE study, phosphodiesterase-5 inhibitor therapy (mono-/combination) does not always have a satisfactory treatment effect. This study aimed to investigate the clinical course of pulmonary...

Descripción completa

Detalles Bibliográficos
Autores principales: Hjalmarsson, Clara, Butler, Oisin, Hesselstrand, Roger, Holl, Katsiaryna, Jansson, Kjell, Klok, Rogier, Rådegran, Göran, Söderberg, Stefan, Kjellström, Barbro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534092/
https://www.ncbi.nlm.nih.gov/pubmed/33062261
http://dx.doi.org/10.1177/2045894020958557

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534092/
https://www.ncbi.nlm.nih.gov/pubmed/33062261
http://dx.doi.org/10.1177/2045894020958557

Ejemplares similares